Further augmentation of molecular responses with dasatinib therapy in chronic myeloid leukemia patients who gained major molecular response under imatinib
Eskazan A. E.
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, cilt.23, sa.2, ss.400-401, 2018 (SCI-Expanded, Scopus)